Illumina and the University Hospital of Tübingen Evaluate Potential of Whole Genome Sequencing to Improve Diagnosis of Full Range of Genetic Diseases

TÜBINGEN, Germany–(BUSINESS WIRE)–February 19, 2021 — Illumina, Inc. (Nasdaq: ILMN) today announced an agreement with the Institute of Medical Genetics and Applied Genomics at the University Hospital of Tübingen to assess the value of whole-genome sequencing (WGS) as a first-line diagnostic test for patients with genetic diseases and familial cancer syndromes. Illumina will support the... Read more

Agilent Announces Immunoassay Kit to Detect SARS-CoV-2 Antibodies

Kit marks first of multiple planned for 2021 aimed at COVID-19  SANTA CLARA, Calif., February 18, 2021  Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent Dako SARS-CoV-2 IgG Enzyme-Linked Immunosorbent Assay (ELISA) kit intended for the qualitative detection of immunoglobulin G (IgG) antibodies to SARS-CoV-2 in human serum or plasma. The kit, which... Read more

Bruker Announces Date and Time of Fourth Quarter 2020 Earnings Release and Webcast

BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced it will report fourth quarter and fiscal year 2020 financial results on Tuesday, February 16, 2021, before the market opens. The Company will host a conference call and webcast at 8:30 a.m. Eastern Standard Time to discuss the results and current business trends. To listen to... Read more

QIAGEN adds dPCR platform QIAcuity to growing portfolio of COVID-19 testing solutions for wastewater and mutation testing

Germantown, Maryland, and Hilden, Germany, January 28, 2021 – QIAGEN today announced the addition of kits for wastewater testing to its growing portfolio of COVID-19 products. The use of dPCR in the worldwide surveillance of COVID-19 is an additional step towards making digital PCR (dPCR) an affordable and standard instrument for a host of applications... Read more

ENPICOM introduces an end-to-end solution for fast and efficient antibody discovery

The new Antibody Discovery Module accelerates and improves candidate selection workflows Caption: ENPICOM’s solution accelerates and improves antibody discovery. To download image, please click here. ‘s-Hertogenbosch (The Netherlands) – January 28, 2020 – Life Science Newswire – ENPICOM BV, an innovative bioinformatics software engineering company, announces a major release of its ImmunoGenomiX (IGX) Platform featuring the new Antibody Discovery Module (ADM). This... Read more

Gyros Protein Technologies introduces Gyrolab Bioaffy 4000 CD to extend sensitivity of immunoassay CD range

Enables researchers to generate more data in less time to support both preclinical and clinical studies Uppsala, Sweden, 27 January 2021: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and a leading provider of peptide synthesizers and reagents, today announced the introduction of Gyrolab® Bioaffy™ 4000 CD for immunoassay applications in biotherapeutic workflows. The new... Read more

Swift Biosciences Releases Targeted S Gene Panel to Accelerate Surveillance of Emerging Strains of SARS-CoV-2

ANN ARBOR, Mich., Jan. 27, 2021 /PRNewswire/ — Swift Biosciences of Ann Arbor, MI  has released a targeted gene panel that covers 100% of the SARS-CoV-2 S gene, even with limited viral titers. The Swift Normalase® Amplicon SARS-CoV-2 S Gene Panel (SNAP) eliminates the need to perform qPCR for library normalization. A pioneer in the development of DNA and RNA library... Read more

Clear Labs Launches Groundbreaking Solution for Enhanced Screening and Genomic Surveillance of SARS-CoV-2 and its Mutations

Leader in Next-Generation Sequencing Automation Workflow Solutions Delivers First Turn-key Solution for Whole Genome Sequencing (WGS) of COVID-19 SAN CARLOS, CALIF. (PRWEB) JANUARY 27, 2021 As the COVID-19 virus mutates, so does this growing list of variants, including B.1.1.7., B.1.351 and L452R. These variants, as well as future mutations, can now be identified in real-time by... Read more